<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>New Soft Tissue Indication for PREVICOX&amp;#174;</title><link>/b/veterinary-news/posts/922</link><description> The first coxib for the treatment of osteoarthritis (OA) in dogs, PREVICOX&amp;#174; (Merial), has now been licensed for the relief of post-operative pain and inflammation following soft tissue surgery. 
 &amp;quot;PREVICOX is the first coxib specifically designed for</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>